40 related articles for article (PubMed ID: 23971660)
1. Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms.
Loftis JM
Psychoneuroendocrinology; 2013 Sep; 38(9):1829-30. PubMed ID: 23810316
[No Abstract] [Full Text] [Related]
2. Editorial: HBsAg seroclearance after pegylated interferon treatment-The beginning of the end.
Mak LY
Aliment Pharmacol Ther; 2023 Nov; 58(10):1103-1104. PubMed ID: 37885169
[No Abstract] [Full Text] [Related]
3. Editorial: HBsAg seroclearance after pegylated interferon treatment-The beginning of the end. Authors' reply.
Gao N; Guan G; Zhao Q; Gao Z
Aliment Pharmacol Ther; 2023 Nov; 58(10):1105-1106. PubMed ID: 37885165
[No Abstract] [Full Text] [Related]
4. Ocular side effects of antirheumatic medications: a qualitative review.
M Castillejo Becerra C; Ding Y; Kenol B; Hendershot A; Meara AS
BMJ Open Ophthalmol; 2020; 5(1):e000331. PubMed ID: 32154367
[TBL] [Abstract][Full Text] [Related]
5. Thrombosis Associated with Viral Hepatitis.
Galli L; Gerdes VE; Guasti L; Squizzato A
J Clin Transl Hepatol; 2014 Dec; 2(4):234-9. PubMed ID: 26357629
[TBL] [Abstract][Full Text] [Related]
6. Managing adverse effects of interferon-alfa and ribavirin in combination therapy for HCV.
Slim J; Afridi MS
Infect Dis Clin North Am; 2012 Dec; 26(4):917-29. PubMed ID: 23083824
[TBL] [Abstract][Full Text] [Related]
7. Retinal vein thrombosis associated with peginterferon alpha 2b plus ribavirin in a chronic hepatitis C patient.
Such Díaz A; Barrueco N; Esteban Alba C; Escobar Rodríguez I
Farm Hosp; 2011; 35(2):93-4. PubMed ID: 20615736
[No Abstract] [Full Text] [Related]
8. Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C.
Zandieh I; Adenwalla M; Cheong-Lee C; Ma PE; Yoshida EM
World J Gastroenterol; 2006 Aug; 12(30):4908-10. PubMed ID: 16937480
[TBL] [Abstract][Full Text] [Related]
9. Leukocytoclastic vasculitis during pegylated interferon and ribavirin treatment of hepatitis C virus infection.
Adişen E; Dizbay M; Hizel K; Ilter N
Indian J Dermatol Venereol Leprol; 2008; 74(1):60-2. PubMed ID: 18187830
[No Abstract] [Full Text] [Related]
10. Branch retinal artery occlusion and central retinal vein occlusion associated with pegylated interferon plus ribavirin combination therapy for chronic hepatitis C.
Watanabe M; Ogasawara S; Takahashi A; Takada J; Tanaka Y; Okuwaki Y; Minamino T; Hidaka H; Nakazawa T; Shibuya A; Koizumi W
Cutan Ocul Toxicol; 2012 Sep; 31(3):253-7. PubMed ID: 22172047
[TBL] [Abstract][Full Text] [Related]
11. [Acute portal thrombosis in patients with hepatitis C treated with pegylated interferon and ribavirin].
Merino Rodríguez B; Díaz Sánchez A; Matilla Peña A; Clemente Ricote G; Núñez Martínez O
Gastroenterol Hepatol; 2008 Jan; 31(1):18-21. PubMed ID: 18218275
[TBL] [Abstract][Full Text] [Related]
12. Retinal thrombosis secondary to the combination therapy of pegylated interferon and ribavirin for chronic hepatitis C virus infection. A rare complication.
Ortega-Ibarra FS; Remes-Troche JM
Rev Esp Enferm Dig; 2013; 105(5):291-2. PubMed ID: 23971660
[No Abstract] [Full Text] [Related]
13. Fatal cardiomyopathy associated with pegylated interferon/ribavirin in a patient with chronic hepatitis C.
Condat B; Asselah T; Zanditenas D; Estampes B; Cohen A; O'Toole D; Bonnet J; Ngo Y; Marcellin P; Blazquez M
Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):287-9. PubMed ID: 16462543
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
